OncoSec Announces FDA Clearance of IND Application for Initiation of Phase 1 Clinical Trial of its CORVax12 Vaccine Candidate for COVID-19 Oct 29, 2020 9:10am EDT
OncoSec Announces Appointment of Sandra Aung, Ph.D. as Senior Vice President, Chief Clinical Development Officer Oct 12, 2020 8:30am EDT
OncoSec Announces Issuance of New U.S. Patent Expanding Coverage of TAVO™ and Its Gene Delivery Platform Oct 06, 2020 8:30am EDT
OncoSec Announces Initiation of a Phase 2 Study at the Moffitt Cancer Center to Evaluate the Combination of TAVO plus OPDIVO® as Neoadjuvant Therapy for Melanoma Aug 27, 2020 8:30am EDT
OncoSec Medical Incorporated Announces Proposed Public Offering of Common Stock Aug 14, 2020 8:42pm EDT
OncoSec to Present at the BTIG Virtual Biotechnology Conference 2020 on Tuesday, August 11, 2020 Aug 10, 2020 8:30am EDT
OncoSec's Novel COVID-19 Vaccine Candidate Featured in 'Straight Talk' Program by NBC TV in Portland, Oregon Jul 13, 2020 9:00am EDT
